Stockchase Opinions

Hugh Cleland, CFA Trillium Therapeutics Inc TRIL-T WATCH Mar 31, 2008

Fascinated by the technology, they’re taking 2 off patent drugs and combining them to use in therapy for stroke victims. Has a lot of potential. Still has some huge upside.
$0.240

Stock price when the opinion was issued

Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

HOLD
(Market Call Minute.) Volatile stock and you can hold it if it hangs in there but be careful.
COMMENT

Pfizer bought it today, and TRIL shares tripled from $6 to $18 in the blink of an eye. That's why he always advises investing in small drug companies; sometimes they pan out.